Pre-market Movers For April 30 (XOM, CI, TEVA, CRM, GLUU, CKSW, POT, CELG, OVTI)

(RTTNews) - Gainers:

Exxon Mobil Corp. (XOM) is up over 1 percent to $89.00. The company's first quarter earnings were sharply lower than in the year-ago quarter, but topped Wall Street view. Total revenues and other income for the quarter declined, yet came above the consensus estimate.

Teva Pharmaceutical Industries Ltd. (TEVA) is up 1 percent to $62.70 as its first quarter results came above market view and as it raised its full-year earnings forecast.

salesforce.com, inc. (CRM) is gaining three-tenths of a percent to $74.89 based on the news that it is working with financial advisers to help it field takeover offers after being approached by a potential acquirer. CRM closed Wednesday's regular trading up 11.60 percent amidst the news.

Glu Mobile, Inc. (GLUU) is rising 26 percent to $6.81 based on the news that Tencent Holdings has agreed to purchase 21 million shares of Glu's stock at a price of $6.00 per share. The company also announced that its first quarter results were above Street view.

OmniVision Technologies, Inc. (OVTI) is up 6 percent to $28.10. The company has agreed to be acquired by a consortium composed of Hua Capital Management Co., Ltd., CITIC Capital Holdings, and GoldStone Investment for $29.75 per share in cash, or a total of approximately $1.9 billion.

ClickSoftware Technologies Ltd. (CKSW) is surging 28 percent to $12.56 as it agreed to be acquired by private funds managed by Francisco Partners Management L.P. in an all-cash transaction valued at approximately $438 million.

Decliners:

Cigna Corp. (CI) is down 1 percent to $125.00 despite reporting first quarter results that were above Street view. The company also raised its 2015 earnings forecast

Potash Corp. of Saskatchewan, Inc. (POT) is down over 2 percent to $32.23 as its first quarter results missed Street view. The company forecast second quarter earnings below market view and also lowered its 2015 earnings guidance.

Celgene Corp. (CELG) is falling 2 percent to $111.00. The company's first quarter adjusted earnings per share topped estimate by a penny, while its revenue missed the consensus estimate. At the same time, the company reiterated its 2015 outlook.